American Pacific buys ingredient manufacturer

American Pacific is buying the assets of Aerojet Fine Chemicals for $119 million and the assumption of some liabilities. AFC makes active pharmaceutical ingredients and registered intermediates for commercial customers in the pharmaceutical industry. It had $66 million in sales last year. "AFC is a perfect fit for our company," said John R. Gibson, CEO of American Pacific. "It is an attractive, profitable business that complements our existing specialty chemical and energetic product portfolio. This acquisition provides us with a strong presence in fast growing pharmaceutical markets where we can provide customers with value added products and services."

- read this press release for more

Suggested Articles

The public financing will enable Monopar to start a phase 3 trial of a prophylactic treatment for a side effect of chemoradiotherapy. 

The dispute centers on whether Asa Abeliovich used Alector’s confidential information in connection with his work for Prevail Therapeutics.

GSK poaches Merck KGaA's Martinez-Davis to helm pharma stateside; Bulto named Novartis U.S. pharma head; Allergan's Saunders set for huge parachute.